A PHASE-II TRIAL OF DIAZIQUONE (AZQ) IN MIXED MESODERMAL SARCOMAS OF THE UTERUS - A GYNECOLOGIC ONCOLOGY GROUP-STUDY

被引：0
|
作者：
SLAYTON, RE
BLESSING, JA
CLARKEPEARSON, D
机构：
[1] RUSH PRESBYTERIAN ST LUKES MED CTR,DEPT MED,MED ONCOL SECT,CHICAGO,IL 60612
[2] ROSWELL PK CANC INST,GYNECOL ONCOL GRP,BUFFALO,NY
[3] DUKE UNIV,MED CTR,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,DURHAM,NC 27710
来源：
INVESTIGATIONAL NEW DRUGS | 1991年 / 9卷 / 01期
关键词：
DIAZIQUONE; MIXED MESODERMAL SARCOMA; UTERUS;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AZQ was given intravenously to 23 patients with mixed mesodermal sarcoma of the uterus refractory to conventional treatment at a dose of 22.5-30 mg/m2 q three weeks. There was one partial response lasting seven weeks and one drug-related death. Based upon the activity observed in this trial, there does not appear to be a significant role for AZQ as a salvage agent for mixed mesodermal sarcomas of the uterus at the dose and schedule tested.
引用
收藏
页码：93 / 94
页数：2
相关论文
共 50 条
  • [41] PHASE-II TRIAL OF MAYTANSINE IN TREATMENT OF ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, T
    EHRLICH, C
    BLESSING, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 424 - 424
  • [42] PHASE-II TRIAL OF CIS-DIAMMINEDICHLOROPLATINUM (CDDP) IN THE MANAGEMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, T
    BLESSING, J
    DISAIA, P
    LAGASSE, L
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 469 - 469
  • [43] PHASE-II STUDY OF ESORUBICIN (4'-DEOZYDOXORUBICIN) IN ADVANCED EPITHELIAL CARCINOMA OF THE OVARY - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    MCGUIRE, WP
    BLESSING, JA
    BERMAN, ML
    INVESTIGATIONAL NEW DRUGS, 1989, 7 (04) : 333 - 336
  • [44] A PHASE-II STUDY OF CARBOPLATIN IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX - (A GYNECOLOGIC ONCOLOGY GROUP-STUDY)
    ARSENEAU, J
    BLESSING, JA
    STEHMAN, FB
    MCGEHEE, R
    INVESTIGATIONAL NEW DRUGS, 1986, 4 (02) : 187 - 191
  • [45] A PHASE-II STUDY OF CHIP IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    MCGUIRE, WP
    BLESSING, JA
    HATCH, K
    DISAIA, PJ
    INVESTIGATIONAL NEW DRUGS, 1986, 4 (02) : 181 - 186
  • [46] PHASE-II TRIAL OF MITOXANTRONE IN ADVANCED SARCOMAS - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    BULL, FE
    VONHOFF, DD
    BALCERZAK, SP
    STEPHENS, RL
    PANETTIERE, FJ
    CANCER TREATMENT REPORTS, 1985, 69 (02): : 231 - 233
  • [47] MITOXANTRONE FOR CARCINOMA OF THE ENDOMETRIUM - A PHASE-II TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP
    MUSS, HB
    BUNDY, BN
    DISAIA, PJ
    EHRLICH, CE
    CANCER TREATMENT REPORTS, 1987, 71 (02): : 217 - 218
  • [48] PHASE-II TRIAL OF ECHINOMYCIN IN ADVANCED COLORECTAL-CANCER - A SOUTHWEST ONCOLOGY GROUP-STUDY
    BROWN, TD
    GOODMAN, PJ
    FLEMING, TR
    TAYLOR, SA
    MACDONALD, JS
    INVESTIGATIONAL NEW DRUGS, 1991, 9 (01) : 113 - 114
  • [49] PHASE-II TRIAL OF CISPLATIN AS 2-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, JT
    BLESSING, JA
    LAGASSE, LD
    DISAIA, PJ
    HOMESLEY, HD
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (03): : 253 - 256
  • [50] A RANDOMIZED CLINICAL-TRIAL OF ADJUVANT ADRIAMYCIN IN UTERINE SARCOMAS - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    OMURA, GA
    BLESSING, JA
    MAJOR, F
    LIFSHITZ, S
    EHRLICH, CE
    MANGAN, C
    BEECHAM, J
    PARK, R
    SILVERBERG, S
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (09) : 1240 - 1245
12345